RALA and chronic pancreatitis: Ral inhibition should thus be considered for ongoing treatment efforts aiming at reprogramming PanIN or PDAC to normal pancreatic cell types such as acinar cells61, and as a potential preventive option in cases of chronic pancreatitis.